Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty.

Pharmacoeconomics · 2026 · PMC13290946 · PMID 41820715

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In that analysis, the difference in SSI incidence rates over 90 days between the two groups did not reach statistical significance (relative risk 1.28; p value 0.11) [ 22 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.